BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
1.500
+0.020 (1.35%)
Sep 17, 2026, 10:38 AM EDT - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $4.4 million as of September 17, 2026. Its market cap has decreased by -53.08% in one year.
Market Cap
4.40M
Enterprise Value
1.20M
1-Year Change
-53.08%
Ranking
Category
Stock Price
$1.50
ChartMarket Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $4.40M, a decrease of -89.55%. That is a compound annual growth rate of -31.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 4.40M | -52.87% |
| Dec 31, 2025 | 9.34M | 85.79% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aemetis | 137.12M |
| Ascent Industries Co. | 134.42M |
| CitroTech | 110.29M |
| Flexible Solutions International | 74.08M |
| Northern Technologies International | 73.31M |
| 5E Advanced Materials | 73.07M |
| Loop Industries | 23.44M |
| Bon Natural Life | 6.97M |